Chuck Burton
Direttore/Membro del Consiglio presso TVAX BIOM
Profilo
Chuck Burton has held director positions at TVAX Biomedical, Inc. and ELIAS Animal Health LLC.
Posizioni attive di Chuck Burton
Società | Posizione | Inizio |
---|---|---|
TVAX BIOM | Direttore/Membro del Consiglio | - |
ELIAS Animal Health LLC
ELIAS Animal Health LLC Miscellaneous Commercial ServicesCommercial Services ELIAS Animal Health LLC operates as a medical biotechnology company that develops treatments for cancer in companion animals. It focuses on developing targeted T cell-based immunotherapy for treating cancer in dogs, cats, and horses that harnesses the power of the animal?s own immune system to eliminate the cancer. The company is headquartered in Olathe, KS. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
TVAX Biomedical, Inc.
TVAX Biomedical, Inc. BiotechnologyHealth Technology TVAX Biomedical, Inc. manufactures and sells healthcare products. It is a biotechnology company, which focuses on the development of targeted cell-based immunotherapies for the treatment of cancer and is performing clinical trials with specific focus on brain cancers. The firm’s proprietary immunologic treatment, TVAX Immunotherapy, uses a patient's cells to create activated, genetically unique cancer-killing T cells that can destroy the patient's cancer cells, including cancer stem cells, which are widely believed to be responsible for cancer growth, spread and metastasis. The company was founded by Gray W. Wood, Frank P. Holladay, Catherine E. Lucasey and Lowell Lynn Tilzer on July 14, 2011 and is headquartered in Lenexa, KS. | Health Technology |
ELIAS Animal Health LLC
ELIAS Animal Health LLC Miscellaneous Commercial ServicesCommercial Services ELIAS Animal Health LLC operates as a medical biotechnology company that develops treatments for cancer in companion animals. It focuses on developing targeted T cell-based immunotherapy for treating cancer in dogs, cats, and horses that harnesses the power of the animal?s own immune system to eliminate the cancer. The company is headquartered in Olathe, KS. | Commercial Services |
- Borsa valori
- Insiders
- Chuck Burton